![]() |
Kekst CNC is handling media for Avista Capital Partners as it acquires Taconic Biosciences, the global leader in the production of genetically engineered rats and mice.
Founded in 1952, Rensselaer, NY-based Taconic ships its rodents worldwide for use in drug discovery and scientific research. It counts 40 of the top 50 pharmaceutical companies as clients.
Avista Capital Partners, a private equity firm, specializes in the healthcare sector. It has more than $8B invested in more than 40 companies.
Rob Girardi, Avista partner said Taconic is poised to continue its growth trajectory in the genetically engineered market due to its “reputation for high-touch consultative services, diversity of high-quality models and proven track record of innovation.”
Kekst CNC’s Daniel Yunger and Hallie Wolff are working the deal.
Publicis Groupe owns Kekst CNC.


Joele Frank handles HealthSpan Partners as it ups its $25 per share offer for Surgery Partners, which uses FTI Consulting for strategic communications counsel.
Wendy’s has turned to Collected Strategies as it rejects what it calls an inadequate, unsolicited and non-binding takeover bid from a group led by Nelson Peltz’s Trian Partners.
Collected Strategies and AdvisRy Partners will handle Kaz Resources when it goes public in a $2B deal during the first half of next year.
FGS Global handles Marvell Technology as the semiconductor giant agrees to acquire Lumentum, a Joele Frank client, in all all-stock transaction worth $115B.
Ross Lovern, who advised clients on such matters as internal and external crises, M&A, litigation, restructurings and shareholder activism as a partner at Kekst CNC, has joined Prosek Partners as a managing director on its special situations team in New York.



